Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $10.1945 per EA under NDC 59651016530. Its NADAC has been published 40 times since Sep 24, 2025.
The High Outlier badge above means this manufacturer's average price in the Emtricitabine and Tenofovir Disoproxil Fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB
Emtricitabine and Tenofovir Disoproxil FumarateStrength
100; 150 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651016530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA211640On Market Since
3/9/2023
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has been published 40 times since Sep 24, 2025, and over the history we have for it it has declined 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1945 per EA |
|---|---|
| All-time high | $11.2736 (Jan 14, 2026) |
| All-time low | $10.1523 (Feb 18, 2026) |
| 52-week high | $11.2736 |
| 52-week low | $10.1523 |
| Median price | $10.5165 |
| Average price | $10.5111 |
| Largest weekly change | -6.7% (Jan 21, 2026) |
| Weeks tracked | 40 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB, manufactured by Aurobindo Pharma Limited, is $10.1945 per EA (NDC 59651016530), effective Jun 24, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has declined 3.8%. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
Since Sep 24, 2025, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has ranged from a low of $10.1523 (Feb 18, 2026) to a high of $11.2736 (Jan 14, 2026), with a median of $10.5165 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB (NDC 59651016530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification